Phase 2 Clinical Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon Cancer: a Multicenter Randomized Placebo-controlled Double-blind Study to Investigate the Efficacy and Safety of ART-123
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Apr 2017
At a glance
- Drugs Thrombomodulin alfa (Primary)
- Indications Colon cancer; Disseminated intravascular coagulation
- Focus Adverse reactions; Therapeutic Use
- Sponsors Asahi Kasei Pharma Corp
- 24 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 12 Jul 2016 Status changed from not yet recruiting to recruiting.
- 16 Jun 2016 New trial record